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Background: Malaria treatments are becoming less effective due to the rapid spread of drug resistant parasites.
Increased understanding of the host/parasite interaction is crucial in order to develop treatments that will be less
prone to resistance. Parasite invasion of the red blood cell (RBC) is a critical aspect of the parasite life cycle and is,
therefore, a promising target for the development of malaria treatments. Assays for analysing parasite invasion
in vitro have been developed, but no equivalent assays exist for in vivo studies. This article describes a novel flow
cytometric in vivo parasite invasion assay.
Methods: Experiments were conducted with mice infected with erythrocytic stages of Plasmodium chabaudi adami
strain DS. Exogenously labelled blood cells were transfused into infected mice at schizogony, and collected blood
samples stained and analysed using flow cytometry to specifically detect and measure proportions of labelled RBC
containing newly invaded parasites. A combination of antibodies (CD45 and CD71) and fluorescent dyes, Hoechst
(DNA) and JC-1 (mitochondrial membrane potential), were used to differentiate parasitized RBCs from uninfected
cells, RBCs containing Howell-Jolly bodies, leukocytes and RBC progenitors. Blood cells were treated ex vivo with
proteases to examine the effects on in vivo parasite invasion.
Results: The staining and flow cytometry analysis method was accurate in determining the parasitaemia down to
0.013% with the limit of detection at 0.007%. Transfused labelled blood supported normal rates of parasite invasion.
Protease-treated red cells resulted in 35% decrease in the rate of parasite invasion within 30 minutes of introduction
into the bloodstream of infected mice.
Conclusions: The invasion assay presented here is a versatile method for the study of in vivo red cell invasion
efficiency of Plasmodium parasites in mice, and allows direct comparison of invasion in red cells derived from two
different populations. The method also serves as an accurate alternative method of estimating blood parasitaemia.
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In vivo. JC-1Background
Malaria is one of the most deadly infectious diseases,
resulting in nearly one million deaths annually [1]. The
symptomatic stage of infection occurs when the merozo-
ite form of the Plasmodium parasite invades circulating
red blood cells (RBCs), and undergoes development and
replication. Interfering with merozoite invasion is regarded
a potentially useful and novel anti-malarial approach, and* Correspondence: patrick.lelliott@students.mq.edu.au
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unless otherwise stated.understanding of the process is relatively advanced. The
merozoite first binds to the RBC at an indiscriminate
orientation before aligning itself so its apical end faces the
RBC surface whereby its binding becomes irreversible [2].
Parasite proteins are then secreted resulting in remodel-
ling of the RBC surface, tight junction formation, and
endocytosis of the merozoite [3-6]. Genetic variations in
the parasite [7-11] and the host [12,13] have been reported
to alter parasite invasion efficiency, and several key protein
interactions have been identified in this process [4,14-16].
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for methods to test and translate these findings in vivo.
This is of particular importance when considering the
interaction between the host’s immune system and invad-
ing merozoite. Indeed, during infection the production of
antibodies against merozoite antigens, which inhibit inva-
sion, is thought to be an important mechanism involved
in malaria immunity [20-22]. In concordance with this, it
has been shown that the parasite possesses several alter-
nate invasion pathways, and that it may switch between
these pathways in response to immune action [5,7,23-25].
The development of vaccines against merozoite antigens,
or other invasion blocking therapies, may, therefore,
benefit from an in vivo invasion assessment, which
would account for the role of the immune system in this
interaction.
Rodent malaria parasites have long been utilized as a
model for human malaria and several rodent Plasmo-
dium species are now in widespread use, including Plas-
modium berghei, Plasmodium chabaudi, Plasmodium
yoelii, and Plasmodium vinckei. These species display
substantial genotypic and phenotypic similarities to the
human malarias Plasmodium falciparum and Plasmo-
dium vivax [26] and, therefore, offer the potential to
explore invasion phenotypes in vivo in mice. However,
to use these models two issues need to be addressed.
Firstly, it is often challenging to accurately determine
parasitaemia in in vivo samples. This is particularly
pertinent at low parasitaemia levels when microscopic
examination of blood smears is impractical. Automated
methods such as flow cytometry are preferred, but accur-
acy can be hindered by the presence of additional cell
types, especially RBC progenitors and leukocytes. Re-
cently, several studies have reported the use of novel
dyes combined with autofluorescence or fluorescently
conjugated antibodies to accurately determine parasit-
aemia in vivo [27-29] and these are explored in this
study. Another option is to use transgenic green fluores-
cent protein (GFP) expressing rodent malarial parasites as
described by Franke-Fayard et al. [30]. However, the use
of these parasites is so far restricted to two species of
rodent malaria, P. berghei strain ANKA [30] and P. yoelii
[31], with other parasite strains less suitable for transgen-
esis due to difficulties in maintaining the parasite in vitro.
Another limitation of these parasites is that they must be
maintained under constant drug selection to preserve a
pure GFP expressing line. The second issue preventing
accurate determination of invasion efficiency in vivo is the
variation in synchronicity and parasitaemia between indi-
vidual animals, which is not as pertinent a problem when
using in vitro cultures. This variation is due to factors
inherent in in vivo studies such as imperfect injection of
the starting dose of parasites, small differences in the age
or weight of individual animals, parasite variability andnatural variation in the immune response to infection.
Furthermore, during an in vivo infection, invasion can
occur over a period of six hours or more making it difficult
to distinguish between invasion and early stage growth
phenotypes. To overcome this drawback it is necessary
to discriminate between newly invaded parasitized RBCs
(pRBCs) and those pRBCs already in circulation. This can
be achieved by fluorescently labelling RBCs before ex-
posing them to the parasite as previously described for
in vitro assays [17,18]. Additionally, in order to avoid
inaccuracies due to inter-individual variation it is also
necessary to include a second population of labelled
cells to act as a control. In this way the treated RBCs, or
RBCs of interest, can be compared to control RBCs
within one animal, thereby negating variations in para-
site synchronicity and environmental conditions.
The study presented here describes a novel flow cy-
tometric in vivo invasion assay, which addresses these
issues. The assay was developed and optimized using
mice infected with P. chabaudi adami strain DS, and
its ability to analyse treatments known to block in-
vasion in in vitro studies was verified. The assay al-
lowed accurate determination of in vivo parasitaemia
in mice, and distinguishes leukocytes, RBC progeni-
tors, and RBCs containing Howell Jolly bodies. The
ability of this assay to analyse the precise time of para-
site invasion and correct for inter-individual variability
through the use of two distinct RBC labels was also
demonstrated.
Methods
Mice and parasites
Mice were housed under controlled temperature (21°C)
with a 12:12 hr light-dark cycle. All procedures were
conducted in accordance with the policies of Macquarie
University and conformed to the National Health and
Medical Research Council (NHMRC) Australian code of
practice. The work was performed under the agreement
Ethics No ARA 2012/017 approved and obtained from
the Animal Ethics Committee at Macquarie University.
For experimental malaria infection stock blood infected
with P. chabaudi adami DS or P. berghei ANKA was
stored at -80°C. 250 μL of thawed parasitized blood was
injected into the intraperitoneal cavity of C57BL/6 donor
mice. Once C57BL/6 donors reached 5-15% parasitaemia
they were anesthetized with isofluorane and bled by car-
diac puncture before being sacrificed. Parasitized blood
was diluted in Krebs’s buffered saline containing 0.2%
glucose according to Jarra and Brown [32], and 1 × 104
parasitized RBCs were injected into the intraperitoneal
cavity of mice to be infected. All experiments were per-
formed on SJL/J mice unless otherwise stated. Mice
were monitored daily by tail bleed using microscopy or
flow cytometry as described.
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Microscopy was used to determine parasitaemia of thin
blood smears or to analyse cells sorted by flow cytometry.
Sorted cells were spun down and concentrated before be-
ing allowed to settle onto glass slides coated with 0.1%
polyethylenimine (PEI) (Sigma-Aldrich, St Louis, MO).
Cells were fixed in methanol for one minute before being
stained in a 10% Giemsa solution (Sigma-Aldrich, St Louis,
MO) at pH 7.4 for 10mins. Parasitaemia was calculated by
counting at least 500 parasitized cells by light microscopy
at 100 × magnification.
Staining of blood samples
Blood samples were prepared for flow cytometry using the
following protocol. 3 μL of tail blood was collected directly
into 50 μL staining solution which contained 12 μM JC-1
(Life Technologies, Carlsbad, CA), 5 μM Hoechst 33342
or 2 μM Hoechst 34580 (Sigma-Aldrich, St Louis, MO),
1 μg/mL Streptavidin PE-Cy7, 1 μg/mL anti-CD45 APC
eFluor 780 (clone 30-F11), and 1 μg/mL anti-CD71 PerCP
eFluor 710 (clone R17217) (eBioscience San Diego, CA) in
MT-Ringer Complete (154 mM NaCL, 5.6 mM KCl,
1 mM MgCl2, 2.2 mM CaCl2, 20 mM HEPES, 10 mM
glucose, 0.5% BSA, 30 U/mL heparin, pH 7.4, 0.22 μM
filter sterilized) pre-warmed to 37°C. Samples were incu-
bated at 37°C for 20 mins before adding 650 μL ice cold
MT-Ringer Complete. Cells were then centrifuged at
750 g for 3 mins at 4°C and re-suspended in 700 μL
MT-Ringer Complete before being analysed using flow
cytometry. Under excitation at 488 nm, JC-1 exhibits a
maximum emission at 530 nm, but at high concentra-
tions it forms aggregates, which shift the emission to
580 nm. In this author’s experience JC-1 stained pRBCs
produced very little fluorescence at 580 nm, therefore,
only results obtained at 530 nm fluorescence are reported.
For the evaluation of SYTO-16, Dihydroethidium, and
Thiazole orange uninfected samples were prepared as de-
scribed [27,29,33]. Briefly, cells were incubated with 1 μg/
mL anti-CD45 APC eFluor 780 and 1 μg/mL anti-CD71
PerCP eFluor 710, along with either 2.5 μM SYTO-16,
5 μg/mL Dihydroethidium, or 100 ng/mLThiazole Orange
for 20 mins at room temperature.
Determining the sensitivity of Hoechst 33342 and JC-1
detection of pRBCs
To assess the sensitivity of the Hoechst/JC-1 staining
method at a different parasitaemia, blood from an in-
fected mouse at approximately 1% parasitaemia was
serially diluted with uninfected blood. Mice were anes-
thetized with isofluorane and bled by cardiac puncture
before being sacrificed. Infected blood was divided into
three aliquots and each aliquot was serially diluted
threefold with uninfected blood a total of five times.
The expected parasitaemia was calculated as the initialparasitaemia (determined by counting of parasites on a
Giemsa stained slide) divided by the dilution factor. For
each dilution the parasitaemia was measured using the
Hoechst/JC-1 flow cytometry method described above
as well as by using Hoechst 33342 or JC-1 fluorescence
alone.
Enzymatic treatment of RBCs
In order to validate the ability of this method to detect
the inhibition of parasite invasion, RBCs were treated
with enzymes reported to inhibit P. falciparum invasion
in vitro as previously described [17]. Briefly, RBCs were
incubated with 20 mU/mL neuraminidase, 0.5 mg/mL tryp-
sin, and 1 mg/mL chymotrypsin in MT-Ringer Complete
for 30 mins at 37°C.
Labelling of RBCs
Donor blood was labelled and transfused into infected
mice using the following protocol. Blood was collected
by cardiac puncture of anesthetized mice and immedi-
ately combined with a one tenth volume of 10× heparin
solution (300 U/mL heparin). Blood was kept at 4°C at all
times. RBCs were treated as described or left untreated
before labelling. For RBC labelling cells were suspended
at 20% haematocrit in MT-Ringer (154 mM NaCL,
5.6 mM KCl, 1 mM MgCl2, 2.2 mM CaCl2, 20 mM
HEPES, pH 7.4, 0.22 uM filter sterilized) with either 10
μg/mL of Hydroxysulfosuccinimide Atto 633 (NHS-
Atto 633) (Sigma-Aldrich, St Louis, MO) or 125 μg/mL
Sulfosuccinimidyl-6-(biotinamido)hexanoate (Sulfo-LC-
NHS-Biotin) (Thermo Fisher Scientific, Waltham, MA)
and incubated at 4°C for 1 hr with constant slow mixing.
Stock solutions of 2 mg/mL NHS-Atto 633 and 25 mg/
mL Sulfo-LC-NHS-Biotin were prepared in dimethylfor-
mamide (DMF) and stored at -20°C. Labelled RBCs were
washed three times with MT-Ringer and resuspended in
MT-Ringer at 40% haematocrit. Treated and untreated
blood was combined in approximately equal proportion
in the two label combinations (untreated Atto633/treated
Biotin, untreated Biotin/treated Atto633). 200 μL of solu-
tion (approximately 2 × 109 RBCs) was injected intra-
vascularly into mice at 2-5% parasitaemia during peak
schizogony and blood samples were taken 30 mins and
3 hrs after injection. Schizogony was at its peak ap-
proximately 6 hrs into the dark cycle.
Flow cytometry and cell sorting
Samples were run and 1,000,000-10,000,000 events were
collected using either BD FACS Diva or BD FACS Sort-
ware with a BD Aria II or BD Influx cell sorter respectively
(BD Biosciences, Franklin Lakes, NJ). The BD Aria II was
equipped with a 50 mW 405 nm laser, 20 mW 488 nm
laser, and 18 mW 633 nm laser while the BD Influx was
equipped with a 100 mW 355 nm laser, 200 mW 488 nm
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excited using the 355 nm laser and detected through a
460/50 filter. Hoechst 34580 was excited using the
405 nm laser and detected through a 460/50 filter. JC-1,
anti-CD71 PerCP eFluor 710 and Streptavidin PE-Cy7
were excited using the 488 nm laser and detected through
530/40, 692/40, and 750LP filters respectively. Atto633
and anti-CD45 APC eFluor 780 were excited using the
633 nm laser and detected through 670/30, 750LP filters
respectively. The RBC and leukocyte population was
selected based on FSC/SSC properties and single cells
were gated based on either trigger pulse width or by
using the FSC peak area to height ratio. Cell sorting was
performed on the BD Influx into collection tubes and
slides prepared as described earlier. Compensation and
further analysis was performed using FlowJo v10.0.6
(Tree Star, Ashland, Oregon, USA).
Results
A novel flow cytometric method to detect parasitized
RBCs in in vivo samples
In preliminary studies using uninfected mice, a flow cy-
tometric cell staining and analysis protocol was tested
that took advantage of the DNA-specific dye, Hoechst
33342, which distinguishes DNA-containing blood cells
[33], in conjunction with fluorescently-labelled antibodies
raised against the leukocyte common antigen (CD45) and
a red cell progenitor marker (CD71) to exclude leukocytes
and non-parasitized nucleated blood cells. It was foundG1 onA BSinglets
D EG3 only (uninfected) G3 only (
Figure 1 Gating strategy of uninfected whole blood from SJL/J mice.
cells, debris, noise and platelets were gated out based on forward scatter/s
selecting anti-CD45 APC eFluor780 negative cells (G2) (B) and RBC progenitor
cells (G3) (C). Finally the remaining cells were gated based on positive DNA st
uninfected (D) and P. chabaudi adami DS infected (E) mice. At each stage
representative image of cells from gate G4 in uninfected mice, which wer
Howell-Jolly bodies (F).that even after excluding Hoechst-CD45 and Hoechst–
CD71 dual-positive events, there remained a Hoechst-
stained population accounting for 0.3-0.9% of blood
cells (Figure 1A-D). Furthermore, the Hoechst fluores-
cence intensity of these cells was equal to that of pRBCs
(Figure 1E). To determine their identity, the cells were
sorted onto glass slides, fixed, stained with Giemsa and
examined under light microscopy. Most of the cells re-
sembled red blood cells, with the addition of intracellu-
lar spherical basophilic-stained particles consistent with
the appearance of Howell-Jolly (HJ) bodies (Figure 1F).
HJ-RBCs were observed at similar frequencies in both
SJL/J and C57BL/6 strains of mice, and were also de-
tected when other nucleic acid-specific dyes, including
SYTO-16, Dihydroethidium, and Thiazole Orange were
used (Additional file 1).
To distinguish HJ-RBCs from pRBCs in blood from
infected mice, the inclusion of a mitochondrial membrane
potential dye, JC-1, which has been used previously in
P. falciparum studies to determine parasite viability, was
investigated [34]. In uninfected samples, fewer than
0.005% of cells were Hoechst 33342 and JC-1 positive
when leukocytes and RBC progenitors were excluded
from analyses (Figure 2A). That is, the vast majority of
Hoechst positive red cells identified above as contain-
ing HJ-bodies, did not stain with JC-1. To determine
the optimal staining conditions of JC-1 blood samples
from P. chabaudi adami DS infected mice at 2-10%
parasitaemia were prepared. Concentrations rangingly
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aining by Hoechst 33342 (G4). Representative results are shown from
only the cells in the previous gate were analysed as indicated. A
e sorted and Giemsa stained is shown, these are characteristic
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Figure 2 Hoechst and JC-1 staining of uninfected and infected
blood. In one experiment blood samples were collected from
uninfected (A) and P. chabaudi adami DS infected (B) mice. In
another experiment blood was collected from uninfected (C) and
P. berghei ANKA infected (D) mice. Blood samples were stained with
JC-1, anti-CD45 APC eFluor780, anti-CD71 PerCP eFluor710, and
Hoechst 33342. Note that plots are a typical representation of results
and instrument voltages were slightly different between experiments.
Samples were gated up to G3 as in Figure 1. A blood sample from a
P. chabaudi adami DS infected mouse at approximately 1% parasitaemia
was split into three aliquots and serially diluted with uninfected blood to
create a dilution curve (E). Calculated parasitaemia was estimated based
on the parasitaemia of the undiluted sample, determined by light
microscopy, and the dilution factor. Measured parasitaemia for
Hoechst was calculated as Q1 + Q2, for JC-1 it was calculated as
Q2 + Q3 and for Hoechst + JC-1 it was calculated as Q2 alone (D).
Error bars represent SEM for the three replicates.
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that optimal staining conditions were incubation with
12 μM of JC-1 for 20 mins at 37°C (Additional file 2).
Under these staining conditions infected samples con-
tained a population of Hoechst 33342 positive and JC-1
positive cells, which corresponded to sample parasitaemia
(Figure 2B). Samples from P. berghei ANKA infected mice
exhibited a similar staining pattern indicating this method
is consistent across different parasite species (Figure 2C, D).In order to make this technique more broadly access-
ible, another DNA dye, Hoechst 34580, was tested,
which can be used with a standard 405 nm violet laser.
Results indicate that although Hoechst 34580 results in
less separation between uninfected and infected RBC
populations, it can be used effectively when combined
with JC-1 and provides similar sensitivity to Hoechst
33342 (Additional file 3). To test the sensitivity of this
staining protocol in distinguishing parasite-infected cells,
infected blood was serially diluted with uninfected blood,
and the percentage of infected cells determined (% parasit-
aemia). The limit of detection was approximately 0.007%
when using JC-1 and Hoechst 33342 together compared
to 0.64% when using Hoechst 33342 alone (Figure 2E).
Finally, this protocol was assessed in the absence of anti-
CD71 and anti-CD45 antibodies. Although sensitivity was
reduced due to an inability to distinguish leukocytes from
infected cells, this method reduced costs and simplified
sample analysis (Additional file 4).
In vivo parasite invasion assay
In addition to a method for quantifying parasitaemia, a
flow cytometric method for quantifying parasite invasion
in vivo was developed. A major hurdle in this type of
analysis is distinguishing parasite invasion from para-
site growth or clearance. To do this it is necessary to
distinguish newly infected RBCs from those already in
circulation. This was achieved by labelling two populations
of RBCs and transfusing them into infected mice. Two cri-
teria had to be met in selecting suitable RBC labels for this
assay. Firstly, labels had to be compatible with the Hoechst/
JC-1 method of pRBC detection and secondly, allow para-
site invasion to occur as normal. Hydroxysulfosuccinimide
Atto 633 (NHS-Atto 633) and sulfosuccinimidyl-6-(bioti
namido) hexanoate (Sulfo-LC-NHS-Biotin) were selected
as suitable labels. The NHS conjugate binds to primary
amines on the surface of RBCs. Both labels were opti-
mized for the minimum concentration required to dis-
tinguish labelled cells from unlabelled, and were clearly
distinguishable from each other without need for com-
pensation (Figure 3A).
To determine that the RBC labels did not affect the abil-
ity of parasites to invade RBCs, blood conjugated with the
two different labels was combined and injected into
infected SJL/J mice during schizogony at 2-10% para-
sitaemia. The time of day was critical in this assay in
order to maximize the number of invasion events. It
was determined that schizogony peaked approximately
half way through the dark cycle, under the conditions
used here, this corresponded to between 10 pm and
2 am. Blood was sampled 30 mins and 3 hrs after injec-
tion, and stained and analysed as described in Methods.
The results showed that the parasitaemia of the two la-
belled populations for each of the infected mice were
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Figure 3 In vivo parasite invasion assay. Blood samples were taken from P. chabaudi adami DS infected SJL/J mice 30 mins and 3 hrs after
injection with labelled RBCs and stained with JC-1, Hoechst 33342, anti-CD45 APC eFluor780, anti-CD71 PerCP eFluor710 and Streptavidin PE-Cy7.
Cells were gated to G3 as described in Figure 1 and then gated based on their respective label (A). Cells from Q1 (Biotin labelled) were gated
based on JC-1 and Hoechst fluorescence and the parasitaemia was determined as Q1b divided by Q1 (B). Similarly, parasitaemia of cells from
Q3 (Atto 633 labelled) was determined as Q3b divided by Q3 (C), and endogenous parasitaemia was determined based on the cells from Q4
(unlabelled). As a control experiment the two labelled RBC populations were untreated (D). To quantify the effect of protease treatment on invasion
one labelled RBC population was treated with trypsin, chymotrypsin and neuraminidase, while the other was left untreated (E). Parasitaemia
ratio calculated as the parasitaemia of the labelled RBCs of interest divided by the parasitaemia of the labelled control RBCs for each individual
sample (F). Results are from five or six infected mice with RBC labels switched between treated and untreated to account for any invasion
difference due to the RBC label. Error bars represent SEM, **p-value < 0.01, ***p-value < 0.001.
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cating that these labels do not differentially affect parasite
invasion. It was however observed that the parasitaemia of
the fluorescently labelled populations varied between mice
and did not correlate with the endogenous parasitaemia of
the host mouse (Additional file 5). This was presumably
due to variations in the number parasites undergoing
schizogony in each mouse during the course of the assay.
It was next determined if this method could be used
to compare rates of invasion between normal cells, and
cells treated ex vivo with a combination of proteases (neur-
aminidase, trypsin, and chymotrypsin) that are known to
remove host cell molecules necessary for merozoite
interaction and entry into red cells [5,8]. Blood collected
from a donor mouse was divided in two. One aliquotwas subjected to protease treatment, and the other was
left untreated. Aliquots were labelled, combined and
injected into infected mice during peak schizogony (see
Additional file 6 for schematic). Blood samples were col-
lected at 30 mins and 3 hrs after injection and parasit-
aemia of the two populations determined (Figure 3B, C,
and E). Similar to the above-mentioned assay results, para-
sitaemia values varied between individual mice (Additional
file 5). However, at each time point the parasitaemia of
protease-treated cells was 30-60% less than in untreated
cells in the same mouse, corresponding to parasitaemia
ratios ranging between 0.4 and 0.7. These differences
were observed at each time point, were irrespective of
the dye combination, and were highly statistically sig-
nificant (Figure 3F and Additional file 5).
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In this report, a novel flow cytometry based assay is pre-
sented which allows the quantification of erythrocytic
parasite invasion in vivo. To develop this assay the speci-
ficity of current fluorescent dyes used for the detection
of pRBCs were evaluated in an in vivo model of malarial
infection. To do this, several DNA specific dyes alone
or in combination previously reported for parasitaemia
measurement were assessed: Hoechst 33342 [33,35],
SYTO 16 [27], Dihydroethidium [29,36], and Thiazole
Orange [33,37]. Surprisingly, it was found that samples
from uninfected mice stained with these dyes resulted
in a positively stained population of 0.3-0.9% which was
considerably larger than previously reported values for
in vivo analysis [27-29]. To explain this discrepancy, this
cell population was isolated and examined. This re-
sulted in the detection of basophilic intra-erythrocytic
staining indicating the presence of Howell-Jolly (HJ)
bodies. HJ-RBCs are usually quite rare in humans, and
are associated with abnormal splenic function [38]. In
mice, some studies report HJ-RBC frequencies in con-
trol animals comparable to the data obtained in this
study [39,40] while others report lower levels [41], it is
not clear why this is the case. HJ-RBCs occur when
remnants of DNA remain in mature RBCs due to in-
complete expulsion of the nucleus during erythropoi-
esis. As pRBCs and HJ-RBCs could not be distinguished
from each other based on DNA staining alone, JC-1, a
mitochondrial membrane dye, was investigated to deter-
mine if it would allow for increased specificity in pRBC
staining. It was found that the combination of mito-
chondrial (JC-1) and nucleic acid stain (Hoechst 33342)
provided an increase in the LOD of pRBCs from 0.64%
to 0.007% compared with Hoechst 33342 alone. Similar
levels of sensitivity were observed in mice infected with
P. chabaudi adami DS or P. berghei ANKA. Although
mitochondrial membrane potential dyes have previously
been employed to assess parasite viability [34,42] and to
determine parasitaemia [43,44] to the best of this au-
thor’s knowledge the combination of these with DNA
specific dyes has not been used to quantify parasitaemia
in vivo. In addition to JC-1 and Hoechst, selective, fluo-
rescently labelled antibodies were employed to detect
and exclude RBC progenitors and leukocytes, further
improving the sensitivity of the assay. As well as using
the Hoechst 33342 dye, which must be excited with a
355 nm (UV) laser, the use of an alternative Hoechst
34580 dye, which is excited by the more commonly
available 405 nm laser, was demonstrated, offering a
broader applicability for this assay. The later dye has
been used previously to measure parasitaemia [45]. In a
practical setting this assay allows accurate quantifica-
tion of parasitaemia down to approximately 0.013% util-
izing a 355/488/633 nm three-laser instrument, with thedetection of pRBCs as low as 0.007%. However, in order
to accurately measure low parasitaemia a sufficient
number of events must be analysed to overcome the
incidence of noise related to sample or machine im-
purities, in some cases this will require the analysis of
> 5,000,000 events.
In addition to parasitaemia measurement a method
was established to directly compare rates of parasite inva-
sion in different RBC donor cells within a single recipient
animal. RBC labels were evaluated that could be detected
in conjunction with the Hoechst and JC-1 dyes, and the
NHS-Atto 633 and Sulfo-LC-NHS-Biotin (combined with
streptavidin PE-Cy7) were selected. To ensure the accur-
acy of this assay the effect these labels might have on para-
site invasion was addressed. Theron et al. [17] suggested
that surface labels, such as FITC, may inhibit invasion,
while Pattanapanyasat et al. [46] report that using biotin
as a surface label has no effect on invasion. Under the
conditions used here, labelling red cells with these mole-
cules did not affect parasite invasion in vivo. The high
quantum yield of the molecules allowed concentrations of
the labels to be minimized. By using two populations of la-
belled cells, rather than one population as used in in vitro
assays [17,18,46], the assay was able to be performed in
mice with variable parasite loads and parasite stage syn-
chronicity with little effect on results. In addition, by opti-
mizing the starting time of this assay to coincide with
peak schizogony significant numbers of newly invaded
RBCs were detected after just 30 minutes; this timeframe
was also sufficient to detect differential invasion rates be-
tween protease-treated and untreated cells. The limited
time frame is likely to specifically reflect an invasion
phenotype, rather than parasite growth as reported in
previous assays [45]. However, results suggest that by
continuing this assay over longer time periods other as-
pects of the parasite life cycle such as growth, splenic
clearance, and sequestration can also be investigated.
Once this assay was established it was determined if
invasion inhibition produced by treatment of RBCs with
trypsin, chymotrypsin, and neuraminidase could be de-
tected. It was found that protease treatment reduced in-
vasion by 35%. This effect on invasion was not as great
as what may be expected, although treatments such as
this have been shown to have variable effect between dif-
ferent strains of P. falciparum parasites [18]. Importantly,
the magnitude of the invasion inhibition was highly
consistent between mice despite differences in parasit-
aemia and synchronization, and was not affected by
label combination.
Conclusions
The ability to accurately study the interaction between
the parasite and its host cell is of utmost importance
in determining factors which are essential for parasite
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vasion have been exclusively carried out in vitro. The
assay presented here allows the accurate measurement
of both parasitaemia and erythrocytic invasion in vivo.
The validity of this assay to detect invasion inhibition
was demonstrated.
Additional files
Additional file 1: Background staining using nucleic acid-specific
dyes. Background staining of HJ-RBCs in uninfected mice was observed
when using the nucleic acid-specific dyes SYTO 16 (A), Thiazole orange
(C) and Dihydroethidium (E). These populations were indistinguishable
from
parasitized cells in equivalent samples from infected mice (B, D, and F).
Additional file 2: Optimization of JC-1 staining. A blood sample was
taken from a P. chabaudi adami DS infected mouse and incubated with
different concentrations of JC-1. Cells were analysed by flow cytometry
(A), and the optimal staining concentration was 12uM as determined by
the ratio of the mean fluorescence intensity (MFI) of the JC-1 positive
population compared to the negative population (B).
Additional file 3: Hoechst 34580 and JC-1 staining of uninfected
and infected blood. Blood samples were collected from uninfected (A)
and P. chabaudi adami DS infected (B) mice and stained with JC-1, anti-CD45
APC eFluor780, anti-CD71 PerCP eFluor710, and Hoechst 34580. Samples
were gated up to G4 as in Figure 1 except that the forward scatter peak
height to area ratio was used to distinguish single cells rather than
trigger pulse width.
Additional file 4: Hoechst and JC-1 staining of uninfected and in-
fected blood without using antibodies. Blood samples were collected
from
uninfected (A) and P. chabaudi adami DS infected (B) mice and stained as
in Figure 2. Samples were gated based on trigger pulse width and FSC/
SSC up to G1 as in Figure 1 without using antibody staining to remove
leukocytes and reticulocytes from the analysis. The overlap between
mature red blood cells (red), leukocytes (orange) and reticulocytes (blue)
is shown (C, D).
Additional file 5: Results from individual infected mice included in
the in vivo parasite invasion assay. Complete data set for each mouse
from the in vivo parasite invasion assays.
Additional file 6: Schematic representation of the In vivo parasite
invasion assay. Blood was collected from uninfected SJL/J mice and
divided into two tubes. One tube is treated with neuraminidase, trypsin,
and chymotrypsin, which are known to inhibit parasite invasion while
the other sample is left untreated (A). These tubes are again divided
into two tubes and one is labelled with Biotin-NHS and the other with
Atto 633-NHS (B). Samples were then combined in two combinations;
Biotin labelled treated RBCs with Atto 633 labelled untreated RBCs and
Atto 633 labelled treated RBCs with Biotin labelled untreated RBCs (C).
These two combinations were injected separately into two lots of in-
fected mice during schizogony at 2-10% parasitaemia (D).
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